ANDRAŠINA, Tomáš, Jiří PÁNEK, Dalibor ČERVINKA, Iva SVOBODOVÁ, Tomáš ROHAN, Jakub HUSTÝ, Hiroko MARTIN and Vlastimil VÁLEK. Prevention of benign stenosis due to endoluminal irreversible electroporation in bile ducts. In CIRSE 2018. 2018. ISSN 0174-1551. Available from: https://dx.doi.org/10.1007/s00270-018-2021-1.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Prevention of benign stenosis due to endoluminal irreversible electroporation in bile ducts
Authors ANDRAŠINA, Tomáš (703 Slovakia, belonging to the institution), Jiří PÁNEK (203 Czech Republic, belonging to the institution), Dalibor ČERVINKA, Iva SVOBODOVÁ (203 Czech Republic), Tomáš ROHAN (203 Czech Republic, belonging to the institution), Jakub HUSTÝ (840 United States of America, belonging to the institution), Hiroko MARTIN (840 United States of America, belonging to the institution) and Vlastimil VÁLEK (203 Czech Republic, belonging to the institution).
Edition CIRSE 2018, 2018.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30224 Radiology, nuclear medicine and medical imaging
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.928
RIV identification code RIV/00216224:14110/18:00103798
Organization unit Faculty of Medicine
ISSN 0174-1551
Doi http://dx.doi.org/10.1007/s00270-018-2021-1
UT WoS 000446679300001
Keywords in English Irreversible electroporation; biodegradable stent; porcine model
Tags International impact
Changed by Changed by: RNDr. Pavel Šmerk, Ph.D., učo 3880. Changed: 31/5/2022 12:17.
Abstract
Purpose To evaluate the possibility of preventing the formation of benign stenosis in healthy bile ducts due to endoluminal irreversible electroporation (IRE). Material and methods Endoluminal IRE of the common bile duct was performed on 15 porcine models using an endoluminal device inserted during laparotomy. The IRE procedure was conducted with 90 pulses of 900-1500 V. Models categorized in group A (n=5) underwent insertion of a biodegradable stent (30x10 mm, Ella-CS) in the ablation site. In group B, the ablation site of the models (n=10) remained untreated. All pigs were euthanized 22 days post-procedure. Biochemical liver tests and MRI were employed for follow-up on days 0, 3, and 22 after ablation. Results The IRE treatment and stent implantation was successful in all procedures. All animals survived over the defined study period. All biodegradable stents remained in place of ablation until the time of autopsy. In group A, serum bilirubin levels were slightly elevated immediately after the procedure (average 19.08 µmol/l compared to 8.33 µmol/l in group B). On day 22, significant elevation of serum bilirubin levels and AST levels were observed in group B (mean 1.73 µmol/l and 18.28 µmol/l, 0.79 µkat/l and 1.74 µkat/l in groups A and B respectively, p<0,05). MRCP sequence on day 22 showed mild or severe dilatation of intrahepatic biliary ducts in a majority of the models (n=9, 90%) in group B. By comparison, the image analysis in group A revealed no intrahepatic dilatation. Conclusion The preventive implantation of biodegradable stents following IRE of bile ducts should be a promising technique to deal with benign stenosis formation after treatment.
Links
MUNI/A/1255/2017, interní kód MUName: Onkologické radiologické intervence a jejich přínos v rámci komplexní onkologické léčby, srovnání s celorepublikovými výsledky onkologické léčby vybraných diagnóz
Investor: Masaryk University, Category A
NV15-32484A, research and development projectName: Využití nových biotechnologií v prevenci a léčbě stenóz žlučových cest
ROZV/24/LF/2018, interní kód MUName: LF - Příspěvek na IP 2108
Investor: Ministry of Education, Youth and Sports of the CR, Internal development projects
PrintDisplayed: 15/10/2024 14:54